Membrane-rigidifying effects of anti-cancer dietary factors

BioFactors

Volumn 16, Issue 3-4, 2002, Pages 45-56

  Tsuchiya, Hironori ^a   Nagayama, Motohiko ^a   Tanaka, Toshiyuki ^b   Furusawa, Miyuki ^b   Kashimata, Masanori ^a   Takeuchi, Hiroshi ^a  

^a ASAHI UNIVERSITY   (Japan)

^b Kakamigahara Gifu 504 0838 Japan   (Japan)

Author keywords

Anti cancer dietary factor; Fluidity; Lipid composition; Liposomal membrane; Membrane rigidifying effect

Indexed keywords

APIGENIN; CHOLESTEROL; DAIDZEIN; DOXORUBICIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; HYDROCARBON; LIPOSOME; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE; QUERCETIN; RESVERATROL;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL MEMBRANE FLUIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; FLUORESCENCE POLARIZATION; HYDROPHILICITY; HYDROPHOBICITY; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE COMPONENT; MEMBRANE MODEL; MEMBRANE STRUCTURE; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0141957272     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520160301     Document Type: Article

References (39)

1. A. Arora, T.M. Byrem, M.G. Nair and G.M. Strasburg. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids, Arch. Biochem. Biophys. 373 (2000), 102-109.
2. Y. Asano, S. Okamura, T. Ogo, T. Eto, T. Otsuka and Y. Niho, Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia, Life Sci. 60 (1997), 135-142.
3. L. Bravo. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance, Nutr. Rev. 56 (1998), 317-333.
4. S. Caltagirone, C. Rossi, A. Poggi, F.O. Ranelletti, P.G. Natali, M. Brunetti, F.B. Aiello and M. Piantelli, Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential, Int. J. Cancer 87 (2000), 595-600.
5. Z.P. Chen, J.B. Schell, C.-T. Ho and K.Y. Chen, Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts, Cancer Lett. 129 (1998), 173-179.
6. R. Clarke, H.W. van den Berg and R.F. Murphy, Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17β-estradiol, J. Natl. Cancer Inst. 82 (1990), 1702-1705.
7. S.S. Daoud, Cell membranes as targets for anti-cancer drug action, Anti-Cancer Drugs 3 (1992), 443-453.
8. A. de la Maza, L. Coderch, O. Lopez and J.L. Parra, Transmission electron microscopy and light scattering studies on the interaction of a nonionic/anionic surfactant mixture with phosphatidylcholine liposomes, Microsc. Res. Tech. 40 (1998), 63-71.
9. G. Deliconstantinos, Physiological aspects of membrane lipid fluidity in malignancy, Anticancer Res. 7 (1987), 1011-1022.
10. T.M.A. Elattar and A.S. Virji, The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells. Anticancer Res. 19 (1999), 5407-5414.
11. H. Fujiki, M. Suganuma, S. Okabe, E. Sueoka, K. Suga, K. Imai, K. Nakachi and S. Kimura, Mechanistic findings of green tea as cancer preventive for humans, Proc. Soc. Exp. Biol. Med. 220 (1999), 225-228.
12. M.H. Gaber, M.M. Ghannam, S.A. Ali and W.A. Khalil, Interaction of doxorubicin with phospholipid monolayer and liposomes, Biophys. Chem. 70 (1998), 223-229.
13. J. Gallovà, J. Cizžmárik and P. Balgavý, Biphasic effect of local anesthetic and β-blocker heptacaine on fluidity of phosphatidylcholine bilayers as detected by ESR spin probe method, Pharmazie 50 (1995), 486-488.
14. H.H. Grunicke, The cell membrane as a target for cancer chemotherapy, Eur. J. Cancer 27 (1991), 281-284.
15. M.G.L. Hertog, P.C.H. Hollman, M.B. Katan and D. Kromhout, Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands, Nutr. Cancer 2 (1993), 21-29.
16. M.G.L. Hertog, P.C.H. Hollman and D.P. Venema, Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits, J. Agric. Food Chem. 40 (1992), 1591-1598.
17. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon and J.M. Pezzuto, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science 275 (1997), 218-220.
18. K. Kitano, K.-Y. Nam, S. Kimura, H. Fujiki and Y. Imanishi, Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A, Biophys. Chem. 65 (1997), 157-164.
19. M.A. Lea, Q. Xiao, A.K. Sadhukhan, S. Cottle, Z.Y. Wang and C.S. Yang, Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia, Cancer Lett. 68 (1993), 231-236.
20. M. Marutaka, H. Iwagaki, T. Suguri, N. Tanaka and K. Orita, Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin, Res. Commun. Mol. Pathol. Pharmacol. 85 (1994), 163-170.
21. C. Morand, C. Manach, V. Crespy and C. Remesy, Respective bioavailability of quercetin aglycone and its glycosides in a rat model, BioFactors 12 (2000), 169-174.
22. K. Nakagawa and T. Miyazawa, Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat, J. Nutr. Sci. Vitaminol. 43 (1997), 679-684.
23. K. Nakagawa, S. Okuda and T. Miyazaki, Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma, Biosci. Biotech. Biochem. 61 (1997), 1981-1985.
24. T. Nakayama, T. Hashimoto, K. Kajiya and S. Kumazawa, Affinity of polyphenols for lipid bilayers, BioFactors 13 (2000), 147-151.
25. M.K. Piskula, Factors affecting flavonoids absorption, BioFactors 12 (2000), 175-180.
26. L. Schoefer, A. Braune and M. Blaut, A fluorescence quenching test for the detection of flavonoid transformation, FEMS Microbiol. Lett. 204 (2001), 277-280.
27. G.V. Sherbet, Membrane fluidity and cancer metastasis, Exp. Cell Biol. 57 (1989), 198-205.
28. M. Shinitzky, Membrane fluidity in malignancy: adversative and recuperative, Biochim. Biophys. Acta 738 (1984), 251-261.
29. H. Simpkins and L.F. Pearlman, Interaction of two second generation platinum antitumor drugs with mouse thymocytes, Cancer Res. 46 (1986), 1433-1439.
30. B. Stavric, Chemopreventive agents in foods, in: Functionality of Food Phytochemicals, T. Johns and J.T. Romeo, eds, Plenum Press, New York, 1997, pp. 53-87.
31. Y.-J. Surh, Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances, Mutat. Res. 428 (1999), 305-327.
32. G. Taraboletti, L. Perrin, B. Bottazzi, A. Mantovani, R. Giavazzi and M. Salmona, Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential, Int. J. Cancer 44 (1989), 707-713.
33. H. Tsuchiya, Effects of green tea catechins on membrane fluidity, Pharmacology 59 (1999), 34-44.
34. H. Tsuchiya, Stereospecificity in membrane effects of catechins, Chem.-Biol. Interact. 134 (2001), 41-54.
35. H. Tsuchiya, Structure-specific membrane-fluidizing effect of propofol, Clin. Exp. Pharmacol. Physiol. 28 (2001), 292-299.
36. H. Tsuchiya, Biphasic membrane effects of capsaicin, an active component in Capsicum species, J. Ethnopharmacol. 75 (2001), 295-299 and Erratum 76 (2001), 313.
37. S. Valcic, B.N. Timmermann, D.S. Alberts, G.A. Wachter, M. Krutzsch, J. Wymer and J.M. Guillen, Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines, Anticancer Drugs 7 (1996), 461-468.
38. W.J. van Blitterswijk, G. de Veer, J.H. Krol and P. Emmelot, Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells, Biochim. Biophys. Acta 688 (1982), 495-504.
39. J. Yu, Y. Cheng, L. Xie and R. Zhang, Effects of genistein and daidzein on membrane characteristics of HCT cells, Nutr. Cancer 33 (1999), 100-104.